Factors associated with diabetes onset were analysed for their predictive value in 708 first-degree relatives of Type 1 (insulin-dependent) diabetic patients including 374 parents and 308 siblings of Type i diabetic patients. Relatives were prospectively followed for 2 304 subject years with blood samples for specific autoantibody evaluation. Islet cell cytoplasmic autoantibody titres were quantified in Juvenile Diabetes Foundation units with a threshold of positivity of 5 units. Insulin autoantibodies were determined using Tyr-A14 iodinated human insulin. HLA typing was performed in 92% of the relatives. During the time of study, 17 of 646 (2.6%) relatives showed islet cell antibodies. During follow-up, eight relatives developed diabetes, including six with high islet cell antibody titre. Taking titres above 20 units increased the positive predictive value from 35% to 75% whereas the presence of insulin autoantibodies did not increase the positive predictive value for the disease. Analysis of metabolic profiles months before the onset of diabetes by either oral or intravenous glucose loads, indicated a considerable level of heterogeneity with relatives with a high islet cell antibody titre who rapidly developed insulin-dependent diabetes, whereas others remained insulin-independent during the same observation period despite comparable titres. This study clearly indicates that initial islet cell antibody titre is not sufficient to predict individual outcome. Follow-up samples are clearly needed to monitor progression of the disease. Few relatives with persistent immunologic positivity progress to clinical Type 1 diabetes, suggesting that non-progressive and sub-clinical Beta-cell dysfunction is common. Despite current knowledge and available genetic and immune markers, early identification of the relatives progressing to clinical diabetes is still difficult and does not allow at the present time aggressive immunointervention at the prediabetic stage.
Summary.
Factors associated with diabetes onset were analysed for their predictive value in 708 first-degree relatives of Type 1 (insulin-dependent) diabetic patients including 374 parents and 308 siblings of Type i diabetic patients. Relatives were prospectively followed for 2 304 subject years with blood samples for specific autoantibody evaluation. Islet cell cytoplasmic autoantibody titres were quantified in Juvenile Diabetes Foundation units with a threshold of positivity of 5 units. Insulin autoantibodies were determined using Tyr-A14 iodinated human insulin. HLA typing was performed in 92% of the relatives. During the time of study, 17 of 646 (2.6%) relatives showed islet cell antibodies. During follow-up, eight relatives developed diabetes, including six with high islet cell antibody titre. Taking titres above 20 units increased the positive predictive value from 35% to 75% whereas the presence of insulin autoantibodies did not increase the positive predictive value for the disease. Analysis of metabolic profiles months before the onset of diabetes by either oral or intravenous glucose loads, indicated a considerable level of heterogeneity with relatives with a high islet cell antibody titre who rapidly developed insulin-dependent diabetes, whereas others remained insulin-independent during the same observation period despite comparable titres. This study clearly indicates that initial islet cell antibody titre is not sufficient to predict individual outcome. Follow-up samples are clearly needed to monitor progression of the disease. Few relatives with persistent immunologic positivity progress to clinical Type 1 diabetes, suggesting that non-progressive and sub-clinical Beta-cell dysfunction is common. Despite current knowledge and available genetic and immune markers, early identification of the relatives progressing to clinical diabetes is still difficult and does not allow at the present time aggressive immunointervention at the prediabetic stage.
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The presence of autoimmune markers in high risk individuals and newly-diagnosed Type 1 (insulin-dependent) diabetic patients [1] as well as experimental animal models where autoimmune effector T cells can cause Betacell destruction [2] , strongly support the concept that Type i diabetes results from an immune mediated phenomenon in genetically susceptible individuals. The morbidity associated with diabetes has encouraged research into ways to cure or prevent this chronic disease. Recent immunointervention trials have indicated that if such treatment is to be effective it should be initiated at the early stages of the disease [3, 4] , at a time where the residual Beta-cell mass is sufficient to fulfill insulin needs. Evidence has accumulated that despite its acute onset, Type 1 diabetes is preceded by a long prodromal period * Members of the Lyons' family study also include Prs EBerthez~-ne, R. Mornex, J. Tourniaire during which Beta-cells are progressively destroyed. Family studies have shown that the majority of those first-degree relatives who became diabetic had islet cell cytoplasmic autoantibodies (ICA) months before diagnosis [5] [6] [7] [8] . However, in order to determine the predictive value of these markers and to analyse the rate of Beta-cell failure, a large number of relatives must be screened for circulating autoantibodies and followed up for long periods. In a previous study [8] , we reported that most ICA positive relatives do not progress to developing the disease, indicating that additional factors are required for the progression of Beta-cell destruction. Further identification of those individuals at very high risk for the disease would be of clinical importance in order to decide the risk/benefit ratio of non-specific immunosuppressive treatment prior to weight loss and ketoacidosis. On the other hand, identification of low risk individuals would have also a beneficial psychological impact. In the workshop. During the last two years, our average results were 90% for validity, 95% for consistency, 95% for specificity and 80% for sensitivity. Insulin autoantibodies were determined by a competitive fluidphase radiobinding assay as previously documented [8] by a modification of the radioassay procedure initially described by Palmer et al. [10] according to international workshop recommendations [11] . Briefly, sera were stripped of insulin with charcoal-Dextran prior to incubation for 5 days at 4~ with 7500 ng/ml of Tyr-A14 monoiodinated insulin (specific activity 270 ~tCi/gg IRI, NovoBiolabs, Bagsvaerd, Denmark). Immune complexes were separated using cold polyethylene glycol. A competitive displacement with 4000 ng/ml of serum of unlabelled human insulin (Lilly, Indianapolis Ind., USA) was performed systematically for each sample to assess specific antiinsulin binding. The mean value + 3SD of 86 normal sera was 1.3%.
Genetic studies
HLA class I and class II alleles were determined by serological methods using reference sera. The distribution of DR alleles in our diabetic population and a control panel of normal individuals has been published [8] . The distribution of high risk haplotypes such as DR3-DQw2 and DR4-DQw8 as well as that of the low risk haptotypes DRw15-DQw6 and DR4-DQw7, was studied in both relatives and probands. In a limited number of cases unsolved by serological HLA DQ typing, DQ-B chain sequence polymorphism at position 57 was also analysed after DNA amplification by the polymerase chain reaction and dot-blot analysis with specific 32p-radiolabelled probes [12] . present prospective study, we examined the influence of genetic and immunological parameters on the metabolic outcome of first degree relatives of Type i diabetic patients and determined the predictive value of these markers for the onset of the disease.
Subjects and methods
All first-degree relatives were enrolled after informed consent in a screening programme for Type 1 diabetes from 1982. The characteristics of this family study referred to as the Lyons' family study have been previously published [8] . Between January 1982 and October 1990, 708 first-degree relatives were enrolled in the screening programme, including 374 parents, 308 siblings, and 26 children of 228 Type i diabetic patients. The mean number of relatives per family tested was 3.1 [1] [2] [3] [4] [5] [6] [7] . This population was composed from 6 multiplex families. Genetic determination was performed in 658 (93%) relatives and 220 (96%) patients. Determination of circulating autoantibodies was done at least once in 646 (91%) individuals upon entry into the study and at least twice in 344 of them. Relatives had 1.6_+ 0.9 blood samples and the total follow-up represented 2 304 person-years with a mean observation period of 3.6 years.
Islet cell cytoplasmic and insulin autoantibodies
Four micron sections of frozen pancreas from a human cadaver of blood group 0 were used as substrates for the indirect immunofluorescence assay, using a sheep anti-human IgG FITC conjugate (Wellcome Laboratories, Beckenham Kent, UK) diluted 1 : 50. The end point titres causing detectable fluorescence were converted in Juvenile Diabetes Foundation (JDF) units using a standard curve raised between end point titres of multiple dilutions of an international reference serum [9] . Our laboratory participated in ICA proficiency tests and in the last JDF sponsored international diabetes
Metabolic studies
The metabolic status of ICA positive relatives was determined after an oral charge of 75 g of glucose (OGTT). Diagnosis of glucose intolerance and diabetes was based on the National Diabetes Data Group recommendations [13] . Insulin secretory reserve was estimated after a 12 h fast in subjects on a diet that included at least 250 g carbohydrate. The intravenous glucose tolerance test (IVGTI') was performed by an intravenous infusion of 0.5 g/kg of glucose administered over 2 min. Blood samples were obtained at 1, 3 and 60 min after glucose injection. The first percentile for the sum of 1 rain + 3 min insulin of the response in 83 control subjects (mean age 22.9 years, range 7-31 years and mean BMI 21.5, range 1%33) was 50 mU/1. Intra-individual variation was 49%, and inter-subject variation calculated in 18 control subjects was 21%. Oral glucose tolerance test (OGTF) was performed after an oral charge of 75 g or 1.5 g/m ~ of glucose depending on the age of the subjects.
Statistical analysis
Relative risks were calculated using the appropriate formulae. Statistical comparisons between entry and the latest follow-up were made using paired t-test. Comparison of ICA titre between groups of relatives was performed using the Mann-Whitney U-test. Results are expressed as mean +_ SD.
Results

Autoantibody determination
The frequency of ICA levels above the limit of detection (5 JDF units) was 2.6% (17 of the 646 those relatives in whom diabetes developed and with one exception, peak antibody levels were found at entry. As indicated in Figure 1 , seven of the eight patients with ICA above 40 JDF units remained subsequently positive including five in whom diabetes occurred. All relatives with low ICA titres at first analysis, became negative in followup samples and none developed diabetes. During the study, two of the 629 (0.3%) ICA negative relatives became diabetic. However, in one subject the length of serum sampling period was too short to exclude any ICA positivity months or years before clinical onset. Altogether, the positive predictive value of ICA increased from 35% to 75% when high titre was taken into account. Insulin autoantibodies (IAA) were determined at least once in 621 relatives. Specific binding values exceeded the upper limit of normal values in 14 relatives (2.2%) ( Table 2 ). Four ICA positive relatives had also IAA and three ICA-IAA positive relatives became diabetic during follow-up (Fig. 2) . Insulin binding activities found initially in two other relatives before diabetes onset [8] , were not confirmed with the competitive IAA test using cold insulin. Among IAA positive relatives the three ICA positive individuals who developed Type i diabetes had higher IAA values (p < 0.001). The two ICA negative relatives who subsequently became diabetic did not have IAA. No significant correlation was found between IAA levels and time from onset of diabetes.
of discordance with their diabetic proband are presented in Table 1 . Ages ranged from 10 to 48 years (mean age 25.1 years) and length of discordance from 2 to 40 years (mean duration 15.3 years). Among the 17 ICA positive relatives, eight remained consistently ICA positive on follow-up, one could be tested only once and seven became ICA negative. One relative became positive during followup. Among ICA positive first degree-relatives, a significant difference in titre was found between those who became diabetic during follow-up (n = 5), and others who remained unaffected (mean titre + SD: 112 + 52 vs 23.5 + 15, n = 7, p < 0.01). ICA titres were above 20 JDF units in all
Genetic analysis
The distribution of class II alleles was analysed in 658 relatives and compared to that of 220 probands and 192 control subjects. As indicated in Table 3 , the repartition of class II alleles and DR-DQ haplotypes in relatives reflected the specific distribution found in the diabetic group. In comparison to control subjects, our panel of first degree relatives showed a two-fold increase in the frequency of DR3 and DR4 alleles as well as a ten-fold increase of DR3/DR4 heterozygotes. The majority, but not all, DR3 DR4 alleles found in relatives were also shared Months from onset of diabetes Fig. 3 . Evolution of islet cell autoantibody (ICA) titres, insulin autoantibody (IAA) levels, 1 st phase insulin response to intravenous glucose tolerance test (IVGTT, and 2h blood glucose levels during oral glucose tolerance test (OGTT) in two relatives who became diabetic during the study with probands. The frequency of high-risk haplotypes such as DR3-DQw2 or DR4-DQw8 shared between relatives and probands was higher than low-risk haplotypes. The six ICA positive and the two ICA negative relatives who developed diabetes during the study had at least one haplotype in common with their diabetic proband but shared haplotypes varied from one individual to another. However, all these relatives had either DR3-DQw2 or DR4-DQw8 haplotypes with 57-Asp negative DQ-B 189 chains. No particular class II allelic combination was associated with a more rapid metabolic deterioration. Presence of ICA or IAA occurred in different genetic combinations. However, the presence of ICA was linked to the presence of 57-Asp negative DQ-B chain at a single or double dose, closely reflecting the genetic background of their diabetic probands. However, the high level of susceptibility due to the presence of high titre ICA was not associated with a specific HLA pattern.
Metabolic outcome of lCA positive relatives
Six out of the eight relatives who developed diabetes underwent an OGTT and/or IVGTT during the prediabetic period. Four individuals had a documented IVGTF below the 1st percentile at the initial test, between 3 and 36 months before the onset of diabetes. No correlation was found between IVGTT values and time from clinical onset. Little variability was found in these subjects with no conversion to normal insulin response to glucose. Fasting blood glucose levels remained within the normal range a few months before onset, although a progressive rise was noticed. Immunologic and genetic parameters could not differentiate relatives with rapid from those with slow and progressive deterioration of Beta-cell function. Figure 3 illustrates the differences in metabolic profiles in two relatives with high titre ICA. While one developed ketoacidosis and insulin deficiency, the other had normal fasting blood glucose levels but remained insulinindependent at the most recent follow-up despite pathological first phase insulin responses and abnormal OGTTs. Both had high risk DQ alleles, ICA at 80 JDF units at entry in the study and IAA in the same range.
Discussion
This study further supports the presence of islet cell and insulin autoantibodies months or years before development of clinical diabetes. Large scale prospective studies [5, 8, 14] . The fact that the majority of ICA -were detected in relatives at entry to the study adds further support to the view that progression to hyperglycaemia may be slow. Indeed, follow-up of ICA negative subjects identified only one identical sibling who became ICA positive shortly before diabetes onset. This result has some importance for the strategy of the screening pro~ grammes and should encourage ways of increasing the number of participants rather than developing the followup of ICA negative individuals which should be maintained in those with the highest genetic risk, Although animal models have clearly indicated that diabetes is a T cell mediated autoimmune disease [2] , presence of ICA remains the best indicator of an ongoing autoimmune process. One of the questions this study was designed to answer, was whether later development of Beta-cell failure could be predicted in ICA positive first degree relatives of diabetic probands. This question remains unanswered due to the occurrence of fluctuating autoantibody levels as well as long periods of ICA positivity without clinical symptoms as previously reported [17] . Variation in substrate sensitivity warrants the conversion of ICA titres into JDF units which increases significantly the positive predictive value. High titre ICA as well as CF-ICA are closely associated with a higher risk of becoming diabetic. All our ICA positive relatives who became diabetic had ICA above 20 JDF units. As previously documented by Bonifacio et al. [16] , quantification of ICA in follow-up samples is therefore clearly needed to accurately predict onset of Type 1 diabetes. However, the results presented here suggest a higher level of heterogeneity. Some individuals with high ICA titres at entry did not develop diabetes within 5 years of follow-up. Others with fluctuating ICA titres became ICA negative during follow-up. In this study, relatives with constant ICA titres above 40 JDF units had a rapid progression to disease. In contrast to previous studies [18, 24] , presence of IAA did not increase in our study the predictive value since only three out of six ICA positive relatives also had IAA prior to diabetes onset and since none of the ICA negative IAA positive individuals developed the disease. In contrast to what could be observed with ICA, we have not found conversion of IAA values over time which suggests that these two autoantibodies are independent and reflect different pathogenic mechanisms. This study also reports on two ICA-IAA negative relatives with high risk haplotypes who became diabetic during follow-up. Impairment of Beta-cell function and peripheral insulin sensitivity has been described in HLA identical siblings of Type 1 diabetic patients [19] . The genetic background may therefore contribute to subclinical Beta-cell dysfunction which may progress in limited cases to clinical diabetes under the influence of immune and environmental factors. Recent molecular findings bring further insights into the genetic susceptibility to Type i diabetes [20] [21] [22] . However, a large number of healthy relatives have the susceptible genes. Additional genetic information therefore needs to be incorporated into a full model of genetic susceptibility, including characterization of both DQ-A and DQ-B chains [22] . In the present study, HLA identity did not expose relatives to an increased prevalence of autoantibodies and metabolic alterations. This is in accordance with the fact that HLA associated genes are thought to contribute less than 50% to the liability.
Alteration of the first phase insulin release during IVGTT has been reported to predict the onset of overt diabetes in pre-diabetic patients within 1.5 years [24] . An important point to be considered is the reproducibility of the measures of Beta-cell function. Some low insulin responders to glucose remained normal after 5 years of follow-up. A decrease in the insulin response to glucose has been reported by Lindgren et al. [25] after puberty. The observation of several relatives who did not progress to insulin-dependency despite low 1 min+3 min insulin values, demonstrates the difficulty in predicting on a single test the metabolic profile and delay from diabetes onset. In addition, normal fasting glucose does not eliminate imminent development of overt disease [26] . The present study and others [27] [28] [29] , do not support a model of linear loss of Beta-cell mass. The preservation of an insulin reserve sufficient to maintain glucose homeostasis raises the possibility of fluctuation in the activity of immune-mediated destruction of the Beta cells. Factors which in some individuals precipitate rapid deterioration of glucose homeostatic function are not known.
Immunosuppression had been found to be efficient in Type i diabetes when given at clinical presentation leading to an increase in the prevalence of complete remissions [3] . However, in order to prevent the disease, such treatment should be given earlier, at a time when the residual Beta-cell mass is sufficient to fulfill insulin needs. The demonstration in ICA positive relatives of a highly variable metabolic outcome emphasizes the difficulties encountered in establishing the value of any preventive treatment given in randomized controlled trials.
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